Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $1.02 in the prior trading day, AN2 Therapeutics Inc (NASDAQ: ANTX) closed at $0.98, down -3.92%. In other words, the price has decreased by -$3.92 from its previous closing price. On the day, 1.91 million shares were traded. ANTX stock price reached its highest trading level at $1.04 during the session, while it also had its lowest trading level at $0.95.
Ratios:
Our goal is to gain a better understanding of ANTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.61 and its Current Ratio is at 10.61. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on August 09, 2024, Downgraded its rating to Market Perform and sets its target price to $1 from $5 previously.
Leerink Partners Upgraded its Market Perform to Outperform on July 03, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’24 when RA Capital Healthcare Fund LP bought 1,699,998 shares for $1.00 per share.
RA Capital Nexus Fund II, L.P. bought 299,999 shares of ANTX for $305,998 on Aug 15 ’24. On Aug 14 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 1,500,000 shares for $1.04 each. As a result, the insider paid 1,560,000 and bolstered with 5,749,432 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANTX now has a Market Capitalization of 29245552 and an Enterprise Value of -81696344.
Stock Price History:
Over the past 52 weeks, ANTX has reached a high of $22.22, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is -56.69%, while the 200-Day Moving Average is calculated to be -88.14%.
Shares Statistics:
The stock has traded on average 452.26K shares per day over the past 3-months and 2164480 shares per day over the last 10 days, according to various share statistics. A total of 29.74M shares are outstanding, with a floating share count of 19.38M. Insiders hold about 33.03% of the company’s shares, while institutions hold 60.56% stake in the company. Shares short for ANTX as of 1722384000 were 683402 with a Short Ratio of 1.51, compared to 1719532800 on 676962. Therefore, it implies a Short% of Shares Outstanding of 683402 and a Short% of Float of 3.55.
